Lifevantage Net Profit Margin 2010-2025 | LFVN

Lifevantage net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Lifevantage Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $0.22B $0.01B 4.05%
2024-12-31 $0.21B $0.01B 3.77%
2024-09-30 $0.20B $0.00B 2.04%
2024-06-30 $0.20B $0.00B 1.50%
2024-03-31 $0.21B $0.00B 1.95%
2023-12-31 $0.21B $0.00B 1.42%
2023-09-30 $0.21B $0.00B 1.41%
2023-06-30 $0.21B $0.00B 1.40%
2023-03-31 $0.21B 0 0.00%
2022-12-31 $0.21B 0 0.00%
2022-09-30 $0.21B $0.00B 0.49%
2022-06-30 $0.21B $0.00B 1.46%
2022-03-31 $0.21B $0.01B 4.29%
2021-12-31 $0.21B $0.01B 4.72%
2021-09-30 $0.22B $0.01B 6.39%
2021-06-30 $0.22B $0.01B 5.88%
2021-03-31 $0.23B $0.01B 5.33%
2020-12-31 $0.23B $0.01B 5.24%
2020-09-30 $0.23B $0.01B 5.19%
2020-06-30 $0.23B $0.01B 5.17%
2020-03-31 $0.23B $0.01B 5.24%
2019-12-31 $0.23B $0.01B 5.24%
2019-09-30 $0.23B $0.01B 3.98%
2019-06-30 $0.23B $0.01B 3.54%
2019-03-31 $0.22B $0.01B 3.13%
2018-12-31 $0.22B $0.01B 3.20%
2018-09-30 $0.21B $0.01B 2.86%
2018-06-30 $0.20B $0.01B 2.96%
2018-03-31 $0.20B $0.00B 1.50%
2017-12-31 $0.19B $0.00B 0.52%
2017-09-30 $0.19B $0.00B 0.52%
2017-06-30 $0.20B $0.00B 0.50%
2017-03-31 $0.20B $0.00B 1.49%
2016-12-31 $0.21B $0.00B 1.88%
2016-09-30 $0.22B $0.01B 2.78%
2016-06-30 $0.21B $0.01B 2.91%
2016-03-31 $0.20B $0.00B 2.02%
2015-12-31 $0.19B $0.00B 2.14%
2015-09-30 $0.18B $0.00B 1.64%
2015-06-30 $0.19B $0.01B 3.68%
2015-03-31 $0.20B $0.01B 4.48%
2014-12-31 $0.21B $0.01B 4.74%
2014-09-30 $0.22B $0.01B 5.58%
2014-06-30 $0.21B $0.01B 4.67%
2014-03-31 $0.21B $0.01B 3.81%
2013-12-31 $0.21B $0.01B 4.39%
2013-09-30 $0.21B $0.01B 2.91%
2013-06-30 $0.21B $0.01B 3.37%
2013-03-31 $0.20B $0.01B 5.97%
2012-12-31 $0.19B $0.00B 2.14%
2012-09-30 $0.16B $0.01B 8.18%
2012-06-30 $0.13B $0.01B 10.32%
2012-03-31 $0.10B $-0.04B -40.63%
2011-12-31 $0.07B $-0.04B -62.86%
2011-09-30 $0.05B $-0.05B -92.31%
2011-06-30 $0.04B $-0.05B -134.21%
2011-03-31 $0.03B $-0.01B -33.33%
2010-12-31 $0.02B $-0.01B -35.00%
2010-09-30 $0.02B $-0.01B -86.67%
2010-06-30 $0.01B $-0.01B -118.18%
2010-03-31 $0.01B $-0.01B -144.44%
2009-12-31 $0.01B $-0.01B -114.29%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.157B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.607B 21.40
Becton Dickinson (BDX) United States $49.443B 12.24
Cardinal Health (CAH) United States $36.666B 19.20
Labcorp (LH) United States $21.405B 17.36
Straumann Holding AG (SAUHY) Switzerland $20.729B 0.00
West Pharmaceutical Services (WST) United States $16.077B 33.70
Cooper (COO) United States $14.393B 18.55
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.630B 14.80
Merit Medical Systems (MMSI) United States $5.605B 27.10
DENTSPLY SIRONA (XRAY) United States $3.234B 9.66
CONMED (CNMD) United States $1.827B 13.67
STAAR Surgical (STAA) United States $0.850B 0.00
Pro-Dex (PDEX) United States $0.135B 14.73